Skip to content

Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513056-15-00
Acronym
PM534-A-001-22
Enrollment
45
Registered
2024-04-30
Start date
2022-12-01
Completion date
Unknown
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

Interventions

None listed

Sponsors

Pharma Mar S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026